|
|
S&P 500
7,358.22
–7.24 (–0.10%)
|
|
Dow Jones
51,848.90
+182.06 (+0.35%)
|
|
NASDAQ
25,476.64
–110.40 (–0.43%)
|
|
Market close: June 26, 2026
|
|
|
Stock Market Today
|
S&P 500, Nasdaq, Dow futures rise as US and Iran call
a halt to attacks
US stock futures climbed on Monday following reports
that the US and Iran have agreed to stop tit-for-tat
attacks that broke out over the weekend, enabling peace
talks to continue.
Nasdaq 100 futures rose 1.2%, while those on the S&P 500
moved up 0.8%, after both indexes closed out last week
with sharp losses.
Contracts on the Dow Jones Industrial Average, which is
less exposed to tech names, put on roughly 0.4%.
Markets headed into a holiday-shortened week on edge
after the US launched strikes on Iranian military
targets over the weekend, which escalated tensions in
the Middle East and renewed concerns over a hit to
global energy supplies.
The strikes came after Washington said Tehran carried
out attacks along the Strait of Hormuz.
President Donald Trump later warned of further military
action, writing on Truth Social that the US may
"militarily complete the job that we very successfully
started. If that happens, the Islamic Republic of Iran
will no longer exist!"
Yahoo
Finance
reports.
|
|
|
Image source: Pexels
|
|
|
EdgeUp
|
💊 AbbVie stock run lifts pricing on $10.9 billion
Apogee deal to six times cost
U.S. cash equities didn’t trade Sunday, so AbbVie’s most
recent close is Friday at $253.35.
That’s a 4.2% gain for the day and up 17.0% since June
18, which was the last session ahead of the Juneteenth
break and before AbbVie’s deal week kicked off.
The scale stands out. With 1.77 billion shares out,
going from $216.49 to $253.35 pushed market value up
around $65 billion.
AbbVie said it will buy Apogee for $10.9 billion in
cash.
Apogee closed Friday at $132.55, about 1.9% under the
$135.11 cash offer.
TechStock²
reports.
|
|
🍎 Apple shares hold steady as buyback talk meets AI
chip strain
Apple Inc. starts Monday trading facing another hurdle
for investors—seeing if its buyback will still help
earnings per share as memory costs shift from a supply
side problem to one coming out of Washington.
Volume tells the story this time. Apple traded at five
times its 65-day average turnover on Friday, though the
shares had already bounced off a $274.21 low.
The stock is still down 4.45% for the week and 7.36% in
a month.
The recovery hasn’t undone that earlier drop.
TechStock²
reports.
|
|
✈️ Palantir and Surf Air Mobility Expand Partnership.
Surf Air soars in pre-market
Palantir Technologies today announced an expansion of
its partnership with Surf Air Mobility, a leading air
mobility platform.
Under the expanded agreement, Palantir and Surf Air
Mobility are committing additional resources to
accelerate the development and commercial release of
SurfOS, including OperatorOS, OwnerOS, and SurfOS
Enterprise Solutions products.
The expanded partnership builds on the successful
commercial launch of BrokerOS and the recent
announcement of a multi-million-dollar contract with
Wheels Up, a leading provider of on-demand private
aviation, to be the launch customer for Enterprise
BrokerOS.
Businesswire
reports.
|
|
🧊 NN, Inc. Announces Significant New Awards for its
NVIDIA Data Center Liquid Cooled Products Business.
Stock up in pre-market
NN, Inc., a global diversified industrial company that
engineers and manufactures high-precision components and
assemblies with Six Sigma quality, today provided an
update on its rapidly growing Data Center business.
NN’s combined Data Center and Electric Grid business is
already its second-largest business, with a further goal
to grow the business into the company’s largest business
by sales.
The Data Center & Electric Grid end markets are top
targeted growth markets for the company, along with
Medical products and Defense and Electronics products.
Globe
Newswire
reports.
|
|
💊 Universe Pharmaceuticals Announces Strategic
Acquisition to Expand Pharmaceutical Patent
Portfolio
Universe Pharmaceuticals Inc., a pharmaceutical producer
and distributor in China, today announced that the
company has entered into a share purchase agreement to
acquire 100% of the issued shares of Best Praise
International Limited, a company that holds five patents
in China with potential applications in pharmaceutical
development, for a total purchase price of $10,751,000,
payable in the form of 4,376,552 Class A ordinary shares
of the company.
The patent portfolio covers several pharmaceutical and
healthcare-related areas, including age-related
diseases, neurodegenerative conditions, cognitive
disorders, cardiovascular-related pharmaceutical
applications, antibacterial compounds, and drug delivery
technologies.
Globe
Newswire
reports.
|
|
|
Don’t miss TradeZero America’s Summer
Promo
|
|
The PDT rule is gone on June 4. To celebrate –
TradeZero America gives you:
- 50% off options contract fees — $0.21 per
contract (down
from $0.42)
- 15% off every eligible locate fee
Automatically applied from June 4 through September
4,
2026. No sign-up code needed. Dormant accounts that
reactivate during the period also qualify. T&Cs
apply.
Active trading and day trading involve substantial
risk
and are not suitable for all investors. Investors
may
lose more than their initial investment.
|
See the full
summer promotion
|
|
|
Join Us Live Tomorrow
|
|
Sharpen your trading skills with free trading education
in our weekly TradeZero Live Podcasts.
Tomorrow, June 30 | 11:00 AM ET
How To Develop a Consistent Trading Process with Bob
Iaccino
|
Save Your
Seat
|
|
|
Trading Strategies
|
with Bob Iaccino, Chief
Market Strategist and Co-Founder of Path
Trading Partners.
|
The Headline Isn't Your Edge. Your Process Is.
After 30 years in markets I've watched traders blow up
the same way over and over: a fast move hits, the brain
goes into emergency mode, and suddenly they're chasing a
story instead of executing a plan. Here's what I've
learned.
Fast moves feel bigger than they are because you're
living through them candle by candle — pull up the daily
chart later and it's just another down day.
The word "why" is usually noise unless it directly
changes your entry, stop, or size. And the most
expensive word in trading is "should" — it's either a
prediction dressed up as analysis or self-judgment
dressed up as a lesson, and either way it pulls you off
your process.
What actually works is replacing all of it with if-then
thinking: if price closes back above this level and
holds, then I take the long with this stop and this
target.
Make your stops hard to reach by anchoring them to real
structure, make your targets easy to reach so you build
consistency, and when a retest hits after a breakout,
manage it with rules, not panic. A theme can build you a
watchlist. Only a process builds you a trade.
|
Read the full
post
|
|
|
Top 5 Movers in Early Pre-Market
|
(All pricing and percent gains are based on Early
Pre-Market from 4:00 AM to 7:00 AM ET)
Stock Analysis reports.
|
1) UPC: Universe
Pharmaceuticals INC
Total gain: +160.14%
|
|
2) DCOY: Decoy
Therapeutics Inc.
Total gain: +114.39%
|
|
|
Total gain: +51.09%
|
|
4) CMCSA: Comcast
Corporation
Total gain: +22.44%
|
|
5) IRDM: Iridium
Communications Inc.
Total gain: +20.82%
|
|
|
Friday's Biggest Movers
|
|
The closing price of the top three market percent
gainers trading near or above $3 on
June 26.
|
All pricing and percent gains are based on regular
market trading hours from 9:30 AM to
4:00 PM ET
Stock Analysis reports.
|
|
Total gain: +161.76%
The company announced that the Company will
effectuate a 1-for-3 share
consolidation of the Company's ordinary shares of
US$0.248 par value each
(the "Share Consolidation"). PR
Newswire
reports.
|
|
2) HON:
Honeywell International Inc.
Total gain: +100.84%
The company announced strategic growth vertical,
leveraging its portfolio of
solar and battery energy storage sites to support
the next generation of digital
infrastructure, milestones like SB 13-2 reinforce
the operational track record
and site development expertise that will serve as
the foundation for that
expansion. PR
Newswire
reports.
|
|
3) WSHP: WeShop
Holdings Limited
Total gain: +69.85%
The stock appeared to be moving on no notable news.
|
|
|
Refer a Friend & Earn Together
|
|
Did you know that it pays to invite your friends to
TradeZero?
|
When they fund a new account with us, you’ll both
receive $100 USD.
T&Cs apply.
|
|
Learn
more
|
|
|
Today’s Notable Earnings
|
Estimate and Actual numbers represent Earnings Per Share in US
Dollars
|
|
|
AVAV
AeroVironment
Q4 2026
|
After Market Close
Estimate: 1.480
Actual: N/A
|
|
|
|
ELTP
Elite Pharmaceuticals
Q4 2026
|
After Market Close
Estimate: N/A
Actual: N/A
|
|
|
|
PETV
PetVivo Hldgs
Q4 2026
|
After Market Close
Estimate: N/A
Actual: N/A
|
|
View more
|
|
Enjoying the DailyEdge?
|
|
Recommend our 5-minute daily digest to a friend by
sharing
this
link.
|
|
|
Parting Thoughts
|
|
“If you want to improve, be content to be thought
foolish and stupid.”
|
|
– Epictetus
|
|
Sourced in: Enchiridion —
GoodReads.
|
|
|
|
TradeZero America, Inc., member of FINRA and
SIPC. Investing involves risk, including the
possible loss of principal.
The information in this newsletter
summarizes the latest market activity and
related news and are provided for
educational purposes only. Any trading
symbols displayed are for illustrative
purposes only and do not constitute a
recommendation by TradeZero to buy, sell, or
hold any investment. This material is not
intended to provide investment advice or to
take into account any individual’s financial
condition, investment objectives, or
requirements.
Stocks experiencing significant price
volatility may involve substantial risk.
Past performance is no guarantee of future
results.
Options trading is not suitable for all
investors as it can involve risk that may
expose investors to significant losses.
Please read the Characteristics and Risks of
Standardized Options, also known as the
Options Disclosure Document (ODD) at OCC.
Any trading strategies discussed are for
educational purposes only and should not be
construed as investment advice or a
recommendation.
Certain information herein has been obtained
from third-party sources believed to be
reliable; however, its accuracy or
completeness cannot be guaranteed. The views
and opinions expressed are those of the
author and do not necessarily reflect the
views or opinions of TradeZero, its
affiliates, or employees.
If you have any specific questions about
TradeZero's brokerage services, please reach
out to the TradeZero Broker Dealer servicing
your jurisdiction.
Copyright © TradeZero 2026. All rights
reserved.
|
|
|
|
